Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in HCV Infected Patients Previously Treated with Placebo: Results of the Deferred Treatment Study (GS-US-342-1446 Study)
Asselah, T., Shafran, S., Bourgeois, S., Lai, C.-L., Cramp, M., Mathurin, P., Willems, B., Nguyen, M.H., Davis, M.N., Huang, K.C., Svarovskaia, E., Osinusi, A., Mcnally, J., Brainard, D., McHutchison,Volume:
64
Year:
2016
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/s0168-8278(16)01619-6
File:
PDF, 125 KB
english, 2016